Related references
Note: Only part of the references are listed.An efficient gene knock-in strategy using 5′-modified double-stranded DNA donors with short homology arms
Yi Yu et al.
NATURE CHEMICAL BIOLOGY (2020)
Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci
Maria Gutierrez-Arcelus et al.
NATURE GENETICS (2020)
CRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer et al.
SCIENCE (2020)
Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection
Kilian Schober et al.
NATURE IMMUNOLOGY (2020)
CRISPR-Based Tools in Immunity
Dimitre R. Simeonov et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
Jianxiang Zhang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells
Harald Hartweger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
Aude G. Chapuis et al.
NATURE MEDICINE (2019)
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
Kilian Schober et al.
NATURE BIOMEDICAL ENGINEERING (2019)
B cells engineered to express pathogen-specific antibodies protect against infection
Howell F. Moffett et al.
SCIENCE IMMUNOLOGY (2019)
T cell engineering for adoptive T cell therapy: safety and receptor avidity
Elvira D'Ippolito et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function
Sharyn Thomas et al.
NATURE COMMUNICATIONS (2019)
Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality
Mohit Sachdeva et al.
NATURE COMMUNICATIONS (2019)
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
Beau R. Webber et al.
NATURE COMMUNICATIONS (2019)
Cancer Neoantigens
Ton N. Schumacher et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
Impact of Historic Migrations and Evolutionary Processes on Human Immunity
Jorge Dominguez-Andres et al.
TRENDS IN IMMUNOLOGY (2019)
CLICK: one-step generation of conditional knockout mice
Yoshiki Miyasaka et al.
BMC GENOMICS (2018)
TCR repertoire evolution during maintenance of CMV-specific T-cell populations
Kilian Schober et al.
IMMUNOLOGICAL REVIEWS (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes
Simon E. Troeder et al.
PLOS ONE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells
Stephan Riesenberg et al.
NATURE COMMUNICATIONS (2018)
Electroporation of mice zygotes with dual guide RNA/Cas9 complexes for simple and efficient cloning-free genome editing
Marie Teixeira et al.
SCIENTIFIC REPORTS (2018)
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth et al.
NATURE (2018)
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta et al.
NATURE (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Emerging Cellular Therapies for Cancer
Sonia Guedan et al.
Annual Review of Immunology (2018)
Cell Biology of T Cell Receptor Expression and Regulation
Andres Alcover et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells
Mateusz Legut et al.
BLOOD (2018)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors
R. Monjezi et al.
LEUKEMIA (2017)
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
M. Neuenhahn et al.
LEUKEMIA (2017)
Gene editing in mouse zygotes using the CRISPR/Cas9 system
Benedikt Wefers et al.
METHODS (2017)
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
Tim Wartewig et al.
NATURE (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
T memory stem cells in health and disease
Luca Gattinoni et al.
NATURE MEDICINE (2017)
Refining strategies to translate genome editing to the clinic
Tatjana I. Cornu et al.
NATURE MEDICINE (2017)
Minimally manipulated murine regulatory T cells purified by reversible Fab Multimers are potent suppressors for adoptive T-cell therapy
Fabian Mohr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
Sara Mastaglio et al.
BLOOD (2017)
Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins
Rolen M. Quadros et al.
GENOME BIOLOGY (2017)
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D. Sommermeyer et al.
LEUKEMIA (2016)
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker et al.
SCIENCE (2016)
T Cell Fate at the Single-Cell Level
Veit R. Buchholz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes
Van Trung Chu et al.
BMC BIOTECHNOLOGY (2016)
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
Paulina J. Paszkiewicz et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Dominik Paquet et al.
NATURE (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver et al.
NATURE (2016)
Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy
Lingfeng Liu et al.
NATURE BIOTECHNOLOGY (2016)
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA
Christopher D. Richardson et al.
NATURE BIOTECHNOLOGY (2016)
Control of T cell antigen reactivity via programmed TCR downregulation
Alena M. Gallegos et al.
NATURE IMMUNOLOGY (2016)
Role of memory T cell subsets for adoptive immunotherapy
Dirk H. Busch et al.
SEMINARS IN IMMUNOLOGY (2016)
T cell-specific inactivation of mouse CD2 by CRISPR/Cas9
Jane Beil-Wagner et al.
SCIENTIFIC REPORTS (2016)
Domain-swapped T cell receptors improve the safety of TCR gene therapy
Michael T. Bethune et al.
ELIFE (2016)
Multiplex Genome-Edited T-cell Manufacturing Platform for Off-the-Shelf Adoptive T-cell Immunotherapies
Laurent Poirot et al.
CANCER RESEARCH (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
Kathrin Schumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens
Michael Hebeisen et al.
FRONTIERS IN IMMUNOLOGY (2015)
Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy
Christian Stemberger et al.
BLOOD (2014)
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
Sojung Kim et al.
GENOME RESEARCH (2014)
Serial Transfer of Single-Cell-Derived Immunocompetence Reveals Stemness of CD8+ Central Memory T Cells
Patricia Graef et al.
IMMUNITY (2014)
TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity
Coen Govers et al.
JOURNAL OF IMMUNOLOGY (2014)
RNAi-mediated TCR Knockdown Prevents Autoimmunity in Mice Caused by Mixed TCR Dimers Following TCR Gene Transfer
Mario Bunse et al.
MOLECULAR THERAPY (2014)
Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping
Paula J. P. de Vree et al.
NATURE BIOTECHNOLOGY (2014)
One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering
Hui Yang et al.
CELL (2013)
Cas9 as a versatile tool for engineering biology
Prashant Mali et al.
NATURE METHODS (2013)
An Efficient Low Cost Method for Gene Transfer to T Lymphocytes
Leonardo Chicaybam et al.
PLOS ONE (2013)
Disparate Individual Fates Compose Robust CD8+ T Cell Immunity
Veit R. Buchholz et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi et al.
NATURE MEDICINE (2012)
Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting
Christian Stemberger et al.
PLOS ONE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
John Scholler et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
CD3 limits the efficacy of TCR gene therapy in vivo
Maryam Ahmadi et al.
BLOOD (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Rapid Re-expression of Retrovirally Introduced Versus Endogenous TCRs in Engineered T cells After Antigen-specific Stimulation
Marleen M. van Loenen et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Coexpression of the T-cell receptor constant α domain triggers tumor reactivity of single-chain TCR-transduced human T cells
Ralf-Holger Voss et al.
BLOOD (2010)
Minimal Amino Acid Exchange in Human TCR Constant Regions Fosters Improved Function of TCR Gene-Modified T Cells
Daniel Sommermeyer et al.
JOURNAL OF IMMUNOLOGY (2010)
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
Gavin M. Bendle et al.
NATURE MEDICINE (2010)
Mixed T cell receptor dimers harbor potentially harmful neoreactivity
Marleen M. van Loenen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
Sachiko Okamoto et al.
CANCER RESEARCH (2009)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets
Christian Stemberger et al.
IMMUNITY (2007)
Targeting the Wilms tumor antigen 1 by TCR gene transfer:: TCR variants improve tetramer binding but not the function of gene modified human T cells
Sharyn Thomas et al.
JOURNAL OF IMMUNOLOGY (2007)
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond
Cyrille J. Cohen et al.
CANCER RESEARCH (2007)
Facilitating matched pairing and expression of TCR chains introduced into human T cells
Jurgen Kuball et al.
BLOOD (2007)
The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins
Thomas G. M. Schmidt et al.
NATURE PROTOCOLS (2007)
Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex
Mirjam H. M. Heemskerk et al.
BLOOD (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice
J Holst et al.
NATURE METHODS (2006)
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
M Cobbold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
T cell receptor recognition motifs govern immune escape patterns in acute SIV infection
DA Price et al.
IMMUNITY (2004)
Retroviral vectors for high-level transgene expression in T lymphocytes
B Engels et al.
HUMAN GENE THERAPY (2003)
Surface T-cell antigen receptor expression and availability for long-term antigenic signaling
AG Schrum et al.
IMMUNOLOGICAL REVIEWS (2003)
Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer
M Knabel et al.
NATURE MEDICINE (2002)
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
T Stanislawski et al.
NATURE IMMUNOLOGY (2001)
Share Paper
